Low dose methotrexate: BAD monitoring guidelines

Last updated: March 12, 2020

The British Association of Dermatologists have produced guidelines for the safe and effective prescribing of methotrexate for skin diseases. Table 1 is a summary of their prescribing and monitoring recommendations, and table 2 details the actions to be taken if test results are found to be abnormal. Use these in conjunction with your local shared care guideline.

Table 1 Prescribing and monitoring recommendations for patients using methotrexate for psoriasis (British Association of Dermatologists 2016)


Table 2 Recommended actions for abnormal test results in patients using methotrexate for psoriasis (British Association of Dermatologists 2016)